Added to YB: 2024-02-13
Pitch date: 2024-02-11
ICVX [bullish]
Icosavax, Inc.
-0.39%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology.
Market Cap
$777.8M
Pitch Price
$15.37
Price Target
19.26 (+26%)
Dividend
N/A
EV/EBITDA
-5.49
P/E
-6.98
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Show full summary:
Icosavax: Tender Offer With Contingent Value Right
$ICVX tender offer: $15/shr+$5 CVR ($4 if IVX-A12 FDA apprvd in 6yrs,$1 if $200M sales in 7). IVX-A12 $10B+ RSV/hMPV mkt opp,55% LOA. Mkt prices CVR at $0.20 vs $2.75 expected in 6-7yrs. CEO sale & HSR refiling concerning but deal likely. Sizeable upside,use caution
Read full article (4 min)